(Q39568237)

13 September 2017

title

Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris (English)

1 reference

13 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6111212

Cardiology and cardiovascular medicine

7 August 2023

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

7 August 2023

author name string

J. B. Schwartz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6111212

7 August 2023

G. Jackson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6111212

7 August 2023

R. E. Kates

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6111212

7 August 2023

D. C. Harrison

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6111212

7 August 2023

language of work or name

English

0 references

publication date

1 April 1981

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:0002870381901253?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

https://api.elsevier.com/content/article/PII:0002870381901253?httpAccept=text/plain

7 August 2023

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

7 August 2023

published in

American Heart Journal

1 reference

13 September 2017

volume

101

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

380-385

1 reference

Atenolol: once-daily cardioselective beta blockade for angina pectoris

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol

7 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension

7 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Atenolol in essential hypertension

7 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Effect of once-daily atenolol on ambulatory blood pressure.

7 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker

7 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Studies on the pharmacokinetics and pharmacodynamics of atenolol in man

7 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Clinical pharmacokinetics of atenolol

7 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Atenolol determination by high-performance liquid chromatography and fluorescence detection

7 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Comparison of the effects on airway conductance of a new selective beta-adrenergic blocking drug, atenolol, and propranolol in asthmatic subjects

7 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Effect of atenolol on ventilatory and cardiac function in asthma

7 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

The effects of atenolol (tenormin) and methyldopa on simple tests of central nervous function

7 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Nature and incidence of unwanted effects with atenolol

7 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Long-Term Clinical Experience with Atenolol-a New Selective β-1-Blocker with Few Side-Effects from the Central Nervous System

7 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability

7 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Atenolol in the Treatment of Angina Pectoris

7 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Angina Pectoris and the Placebo Effect

7 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Propranolol serum levels during twenty-four hours

7 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy

7 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

7 August 2023

Drug therapy: metoprolol

26

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

Clinical Pharmacokinetics of β-Adrenoreceptor Blocking Drugs

7 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90125-3

7 August 2023

Identifiers

1 reference

13 September 2017

1 reference